Malignant Neoplasm of Stomach Terminated Phase 2 Trials for Sorafenib (DB00398)

Also known as: Gastric Cancers / Stomach Cancer / Gastric cancer / Gastric Malignancies / Gastric cancer NOS / Cancer of Stomach / Malignant neoplasm of stomach, unspecified / Gastric malignancy

IndicationStatusPhase
DBCOND0045917 (Malignant Neoplasm of Stomach)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00595985Sorafenib as a Second Line Treatment in Patients With Advanced or Metastatic Gastric CancerTreatment